Glen Harbor Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.11M Hold
22,736
0.02% 452
2019
Q2
$1.19M Sell
22,736
-2,912
-11% -$147K 0.02% 434
2019
Q1
$1.27M Buy
25,648
+2,912
+13% +$131K 0.03% 413
2018
Q4
$823K Buy
22,736
+560
+3% +$23.4K 0.02% 473
2018
Q3
$1.13M Buy
22,176
+4,256
+24% +$189K 0.02% 442
2018
Q2
$663K Hold
17,920
0.01% 554
2018
Q1
$677K Hold
17,920
0.02% 526
2017
Q4
$580K Buy
17,920
+2,240
+14% +$71.2K 0.01% 592
2017
Q3
$474K Buy
15,680
+2,016
+15% +$59.8K 0.01% 612
2017
Q2
$401K Buy
13,664
+6,272
+85% +$171K 0.01% 654
2017
Q1
$188K Buy
7,392
+672
+10% +$17.3K ﹤0.01% 756
2016
Q4
$173K Buy
+6,720
New +$177K ﹤0.01% 728

Other funds holding TECH

Glen Harbor Capital Management's TECH Position: Q3 2019 in Review

Glen Harbor Capital Management held its Bio-Techne (TECH) position steady in Q3 2019 at 22,736 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #452.

Glen Harbor Capital Management first reported a position in TECH in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.27M in Q1 2019. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Glen Harbor Capital Management held 22,736 shares of Bio-Techne worth $1.11M as of Q3 2019.
  • Glen Harbor Capital Management left its Bio-Techne share count unchanged in Q3 2019.
  • Bio-Techne made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #452 holding.
  • Glen Harbor Capital Management first reported a position in Bio-Techne in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Bio-Techne position peaked at $1.27M in Q1 2019.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.